Health & Fitness
Health and Fitness
Health and Fitness
Mon, October 17, 2011
Sun, October 16, 2011
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011
Incyte to Report Third Quarter 2011 Financial Results and Provide Update on Key Clinical Programs on October 27
WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its third quarter 2011 financial results conference call for 8:30 a.m. ET on Thursday, October 27, 2011. The schedules for the press release and conference call are as follows:
| -- Q3 2011 Press Release: | October 27, 2011 at 7:00 a.m. ET | |
| -- Q3 2011 Conference Call: | October 27, 2011 at 8:30 a.m. ET | |
| -- Domestic Dial In Number: | 877-407-8037 | |
| -- International Dial In Number: | 201-689-8037 | |
| -- Conference ID # | 380549 | |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 380549.
The conference call will also be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].
